IL-6 Induced Lncrna MALAT1 Enhances TNF-α Expression in LPS-induced Septic Cardiomyocytes Via Activation of SAA3.

Y. -T. Zhuang,D. -Y. Xu,G. -Y. Wang,J. -L. Sun,Y. Huang,S. -Z. Wang
2017-01-01
Abstract:OBJECTIVE: This study aimed to explore the expression of MALAT1 and its correlation with TNF-alpha production in lipopolysaccharide (LPS)-induced septic cardiomyocytes. Then, the effect of metastasis-associated lung adenocarcinoma transcript 1 (MALAT1) on LPS-induced cardiomyocyte apoptosis is further studied. MATERIALS AND METHODS: The hub genes in cell response to LPS treatments was analyzed by using Affymetrix gene profiling data down-loaded from GEO dataset (GSE3140). Mice model of sepsis was induced by intraperitoneal injection of LPS. HL-1 cells were used as the in vitro cell model. MALAT1 and serum amyloid antigen 3 (SAA3) expression were measured by the qRT-PCR analysis. IL-6, TNF-alpha, and SAA3 concentrations were quantified by the ELISA assay. Flow cytometric analysis and TUNEL assay were performed to detect cell apoptosis. RESULTS: IL-6 is a hub gene in cell response to LPS treatment and induces MALAT1 upregulation in cardiomyocytes. MALAT1 siRNA had an inhibitive effect, while MALAT1 overexpression showed enhancing effect on LPS induced TNF-a elevation. HL-1 cells treated with LPS had significantly elevated SAA3 expression. Inhibition of SAA during LPS treatment significantly reduced the TNF-alpha expression, while the addition of apo SAA significantly abrogated the suppressive effect of MALAT1 siRNA on TNF-alpha expression. HL-1 cells transfected with MALAT1 siRNA were less susceptible to LPS-induced cell apoptosis and with a lower apoptosis rate than the control group. CONCLUSIONS: IL-6 induced MALAT1 upregulation in cardiomyocytes in response to LPS treatment. MALAT1 can enhance TNF-a expression at least partly via SAA3 in LPS-treated car-diomyocytes. MALAT1 upregulation is a mechanism of cardiomyocyte death in response to the LPS stimulation.
What problem does this paper attempt to address?